|
A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release. |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - TeneoBio |
| |
|
|
| |
|
|
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - TeneoBio |
| |
|
|
| |
|
|
| |
|
No Relationships to Disclose |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - TeneoBio |
| |
|
|
| |
|
No Relationships to Disclose |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - TeneoBio |
| |
|
|
|
Stock and Other Ownership Interests - TeneoBio |
Patents, Royalties, Other Intellectual Property - TeneoBio |